TrialEuropean journal of neurology2017

Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies.

E Havrdova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.